Tag Archives: Says

Battered company behind peanut-allergy therapy says it’s ready to move forward – MarketWatch

DBV Technologies, whose stock took a beating after the company withdrew its marketing application for a peanut-allergy therapy in December, said Wednesday it is making the necessary changes to re-file later this year. DBV DBVT, +9.22%   pulled the application for its lead drug candidate, Viaskin Peanut, after the U.S. Food and Drug Administration expressed… Read More »

Flu Season Far From Over, CDC Says

FRIDAY, Feb. 8, 2019 (HealthDay News) — Though much of the United States is in the grip of the flu, the season hasn’t peaked yet, health officials said Friday. As of Feb. 2, flu is widespread in 47 states, and 24 states are experiencing high levels of the disease. In addition, hospitalizations are increasing, according… Read More »